Engineered for immediate collagen synthesis, SMAS tightening, and long-lasting tissue regeneration across clinics in Tbilisi, Batumi, and Kutaisi.
As Georgia rapidly emerges as a strategic hub for medical tourism and advanced dermatological care within the Caucasus region, the demand for high-tier firming and lifting injectables, PDO thread vectors, and bioremodeling solutions has experienced exponential growth.
Dermatological patient demographics in Georgia require formulas that address both environmental photofacials and severe structural laxity. Microclimate fluctuations between humid coastal regions like Batumi and continental inland zones like Tbilisi call for multi-depth moisture retention coupled with robust collagen structural support.
Modern Georgian patients increasingly bypass traditional invasive rhytidectomy in favor of hybrid protocols combining Poly-L-Lactic Acid (PLLA) fillers, PCL essence liquid, and high-tensile fishbone PDO/PCL cog threads for natural, dynamic facial contouring without extensive downtime.
Georgia’s regulatory environment favors CE-marked, ISO 13485-certified medical devices and cosmetic formulations. Distributors seeking consistent market share must rely on manufacturers capable of guaranteeing complete batch traceability, rigorous stability testing, and cold-chain compliance.
Our R&D laboratories engineer multi-layer skin rejuvenation systems that address dermal thinning, SMAS ptosis, and vascular degradation simultaneously.
Utilizing high-tensile Polydioxanone (PDO) and Polycaprolactone (PCL) bi-directional fishbone cog threads, our lifting matrices physically elevate sagged superficial muscular aponeurotic system (SMAS) tissue. Over 180 to 360 days, the micro-helical structures degrade safely via hydrolysis, leaving behind a robust structural scaffold of dense Type I collagen.
Unlike standard cross-linked Hyaluronic Acid fillers that simply space-fill, our Injectable Poly-L-Lactic Acid (Reborn PLLA) and Bellona PCL formulations trigger a sustained sub-clinical inflammatory cascade. Macro-phages clear the micro-spheres, recruiting fibroblasts to synthesize native extracellular matrix (ECM) components over 24 months.
At the mitochondrial level, Nicotinamide Adenine Dinucleotide (NAD+) essence recharges ATP production in stressed skin cells, while Deanol (DMAE 7%) enhances acetylcholine release at the neuromuscular junction, inducing immediate cutaneous tension and visible lifting of eyelid and jawline contours.
Founded in 2009, Jiangsu Menuka Medical Co., Ltd. is a leading innovator in the field of medical skincare and dermatological solutions. As a modern enterprise integrating R&D, intelligent manufacturing, clinical application, and global distribution, Menuka Medical is dedicated to advancing the future of professional skincare through science, safety, and innovation.
With years of expertise in dermatology and post-procedure skincare, Menuka Medical continuously develops advanced formulations and functional skincare products supported by patented technologies, clinical validation, and strict quality standards. Our products are specially designed to address sensitive skin conditions, aesthetic recovery, and professional dermatological care.
Today, Menuka Medical has established long-term partnerships with distributors, medical institutions, and skincare professionals across more than 15 countries and regions worldwide. We continue to seek experienced and visionary global partners to expand our international network and bring advanced skincare solutions to broader markets.
At Menuka Medical, we believe skincare is more than a daily routine — it is a professional solution that enhances skin health, confidence, and quality of life.
Formulated based on rigorous pharmacological trials to deliver measurable skin tightening, wrinkle attenuation, and structural lifting.
Extensive biocompatibility testing ensures ultra-low immune reactivity and maximum tissue integration even in sensitive skin types.
Continuous R&D investment yields state-of-the-art micro-encapsulation, bio-fermentation, and specialized cross-linking platforms.
More than 10,000 hospitals, clinics, and professional skincare institutions worldwide trust Menuka Medical for advanced dermatological skincare solutions. Our commitment to innovation, product quality, and customer satisfaction has earned us strong recognition in both domestic and international markets. By closely following global skincare trends and continuously investing in research and development, Menuka Medical remains at the forefront of medical skincare innovation.
Our class 100,000 cleanroom workshops are equipped with fully automated aseptic production pipelines ensuring maximum purity, sterile consistency, and scalable batch output for our global aesthetic partners.
Pioneering next-generation biomaterial synthesis to provide non-surgical firming and lifting solutions with unprecedented kinetic longevity.
Integrating plant and mesenchymal stem-cell derived exosomes into micro-dermo-fillers to accelerate tissue repair pathways and optimize extracellular matrix remodeling following PDO thread deployment.
Next-generation Polycaprolactone formulations with tailorable degradation kinetics (from 12 months to 36 months), permitting individualized collagen stimulation curves based on regional age-demographics in Georgia.
Combining immediate volumetric expansion through soft cross-linked HA with long-term dermal thickening via bio-compatible Poly-L-Lactic Acid microparticles in a single pre-filled syringe solution.
Explore our full line of injectable dermal fillers, thread lifting systems, mesotherapy cocktails, and energetic anti-aging platforms.
As we continue expanding our global presence, Jiangsu Menuka Medical Co., Ltd. welcomes distributors, medical partners, and skincare professionals worldwide to collaborate with us. Together, we are shaping the future of dermatology skincare through science, innovation, and professional excellence.
Tailor active peptide concentrations, viscous viscosity indexes, or Polycaprolactone micro-sphere ratios to suit specific clinical preferences and market positioning across Eurasian clinics.
Full support for localized labeling in Georgian or English, multi-lingual package inserts, tamper-evident security holographic seals, and custom blister packaging.
Complete provision of Certificate of Analysis (CoA), ISO 13485 documentation, CE certification dossiers, and clinical trial summary reports to streamline customs clearance in Poti / Batumi ports.
Essential answers for Georgian distributors, clinic managers, and aesthetic procurement professionals.
Expand your clinic portfolio or distribution catalog with clinically validated, high-yield aesthetic solutions supported by Jiangsu Menuka Medical Co., Ltd.
Send Inquiry Now
Menuka Medical